drugset / Trial / NCT00517634

Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects

NCT00517634

Phase 4 Completed 23 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the present study is to investigate whether the effects of salmeterol in combination with fluticasone propionate on blood markers of airway inflammation are maintained after chronic dosing and whether the effect is influenced by the time of allergen challenge relative to the time of dosing.

Timeline

Start
2007-08
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 100 ug
Subject Salmeterol Other / unclassified 50 ug

Indications